对美国国家科学院/英国皇家学会关于. 的报告的反应。
Reactions to the National Academies/Royal Society Report on .
出版信息
CRISPR J. 2020 Oct;3(5):332-349. doi: 10.1089/crispr.2020.29106.man.
Abstract
In September 2020, a detailed report on was published. The report offers a translational pathway for the limited approval of germline editing under limited circumstances and assuming various criteria have been met. In this perspective, some three dozen experts from the fields of genome editing, medicine, bioethics, law, and related fields offer their candid reactions to the National Academies/Royal Society report, highlighting areas of support, omissions, disagreements, and priorities moving forward.
摘要
2020 年 9 月，发表了一份关于 的详细报告。该报告提供了一条在有限情况下对种系编辑进行有限批准的转化途径，假设已满足各种标准。从这个角度来看，来自基因组编辑、医学、生物伦理学、法律和相关领域的三十多位专家对美国国家科学院/英国皇家学会的报告提出了坦率的反应，强调了支持、遗漏、分歧和优先事项。
相似文献
1
Reactions to the National Academies/Royal Society Report on .对美国国家科学院/英国皇家学会关于. 的报告的反应。
CRISPR J. 2020 Oct;3(5):332-349. doi: 10.1089/crispr.2020.29106.man.
2
Fading red lines? Bioethics of germline genome editing.逐渐消失的红线？生殖系基因组编辑的生物伦理学
Bioethics. 2020 Jan;34(1):3-6. doi: 10.1111/bioe.12709.
3
Geneva Statement on Heritable Human Genome Editing: The Need for Course Correction.日内瓦人类基因组编辑可遗传宣言：需要进行路线修正。
Trends Biotechnol. 2020 Apr;38(4):351-354. doi: 10.1016/j.tibtech.2019.12.022. Epub 2020 Jan 31.
4
License heritable gene editing like medical cannabis.像医用大麻一样批准可遗传基因编辑。
Nature. 2019 Jun;570(7762):446. doi: 10.1038/d41586-019-01971-4.
5
National Academies relax stance on germline edits.美国国家科学院放宽对生殖系编辑的立场。
Nat Biotechnol. 2017 Apr 11;35(4):295-296. doi: 10.1038/nbt0417-295.
6
Does human genome editing reinforce or violate human dignity?人类基因组编辑增强还是侵犯了人类尊严？
Bioethics. 2020 Jan;34(1):33-40. doi: 10.1111/bioe.12607. Epub 2019 Jun 20.
7
Playing it Safe? Precaution, Risk, and Responsibility in Human Genome Editing.谨慎行事？人类基因组编辑中的预防、风险与责任
Perspect Biol Med. 2020;63(1):111-125. doi: 10.1353/pbm.2020.0009.
8
Germline Modification and Policymaking: The Relationship between Mitochondrial Replacement and Gene Editing.生殖系修饰与政策制定：线粒体替代与基因编辑之间的关系
New Bioeth. 2018 Apr;24(1):74-94. doi: 10.1080/20502877.2018.1443409.
9
Genome editing: science, ethics, and public engagement.基因组编辑：科学、伦理与公众参与。
Lancet. 2017 Aug 12;390(10095):625. doi: 10.1016/S0140-6736(17)32209-2.
10
Heritable human genome editing: Research progress, ethical considerations, and hurdles to clinical practice.可遗传的人类基因组编辑：研究进展、伦理考虑和临床实践的障碍。
Cell. 2021 Mar 18;184(6):1561-1574. doi: 10.1016/j.cell.2021.02.036.
引用本文的文献
1
Stem cell therapy: a revolutionary cure or a pandora's box.干细胞疗法：是革命性的治愈方法还是潘多拉魔盒。
Stem Cell Res Ther. 2025 May 22;16(1):255. doi: 10.1186/s13287-025-04334-1.
2
Recent Developments in the Regulation of Heritable Human Genome Editing.人类可遗传基因组编辑的监管新进展
J Bioeth Inq. 2024 Mar;21(1):15-18. doi: 10.1007/s11673-023-10332-w. Epub 2024 Apr 3.
3
Gene editing for dyslipidemias: New tools to "cut" lipids.基因编辑治疗血脂异常：“切割”脂质的新工具。
Atherosclerosis. 2023 Mar;368:14-24. doi: 10.1016/j.atherosclerosis.2023.01.010. Epub 2023 Jan 14.
4
Synthetic Biology Design as a Paradigm Shift toward Manufacturing Affordable Adeno-Associated Virus Gene Therapies.合成生物学设计作为一种向制造负担得起的腺相关病毒基因疗法的范式转变。
ACS Synth Biol. 2023 Jan 20;12(1):17-26. doi: 10.1021/acssynbio.2c00589. Epub 2023 Jan 10.
5
Governing Heritable Human Genome Editing: A Textual History and a Proposal for the Future.治理可遗传的人类基因组编辑：文本历史与未来建议。
CRISPR J. 2021 Aug;4(4):469-476. doi: 10.1089/crispr.2021.0043.
6
Gene Editing: How Can You Ask "Whether" If You Don't Know "How"?基因编辑：不知“如何”，焉能问“可否”？
Hastings Cent Rep. 2021 May;51(3):13-17. doi: 10.1002/hast.1256.
7
Addressing the dark matter of gene therapy: technical and ethical barriers to clinical application.解决基因治疗的暗物质：临床应用的技术和伦理障碍。
Hum Genet. 2022 Jun;141(6):1175-1193. doi: 10.1007/s00439-021-02272-5. Epub 2021 Apr 8.
本文引用的文献
1
Extensive germline genome engineering in pigs.猪的广泛种系基因组工程。
Nat Biomed Eng. 2021 Feb;5(2):134-143. doi: 10.1038/s41551-020-00613-9. Epub 2020 Sep 21.
2
Global citizen deliberation on genome editing.全球公民对基因编辑的审议。
Science. 2020 Sep 18;369(6510):1435-1437. doi: 10.1126/science.abb5931.
3
Safety of Germline Genome Editing for Genetically Related "Future" Children as Perceived by Parents.家长对遗传相关“未来”子女进行种系基因组编辑的安全性看法。
CRISPR J. 2019 Dec;2(6):370-375. doi: 10.1089/crispr.2019.0010. Epub 2019 Nov 19.
4
Heritable Genome Editing and the Downsides of a Global Moratorium.可遗传基因组编辑与全球暂停带来的弊端。
CRISPR J. 2019 Oct;2(5):272-279. doi: 10.1089/crispr.2019.0016.
5
Germline genome editing versus preimplantation genetic diagnosis: Is there a case in favour of germline interventions?胚系基因组编辑与胚胎植入前遗传学诊断：胚系干预有其合理之处吗？
Bioethics. 2020 Jan;34(1):60-69. doi: 10.1111/bioe.12635. Epub 2019 Aug 25.
6
Should Long-Term Follow-up Post-Mitochondrial Replacement be Left up to Physicians, Parents, or Offspring?线粒体替代后的长期随访应该由医生、父母还是后代来决定？
New Bioeth. 2019 Dec;25(4):318-331. doi: 10.1080/20502877.2019.1654672. Epub 2019 Aug 20.
7
Do CRISPR Germline Ethics Statements Cut It?CRISPR生殖系伦理声明可行吗？
CRISPR J. 2018 Apr;1(2):115-125. doi: 10.1089/crispr.2017.0024.
8
Questioning the proposed translational pathway for germline genome editing.对生殖系基因组编辑的拟议转化途径提出质疑。
Nat Hum Behav. 2019 Mar;3(3):200. doi: 10.1038/s41562-019-0544-3.
Zotero 插件